Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
Clinical trial NCT05141253 · RECRUITING
Trial details
- NCT number
- NCT05141253
- Sponsor
- Tongji Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2023-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.